Vaccinex Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Maurice Zauderer
Chief executive officer
US$430.3k
Total compensation
| CEO salary percentage | 95.7% |
| CEO tenure | 23yrs |
| CEO ownership | 0.2% |
| Management average tenure | 15.3yrs |
| Board average tenure | 20.2yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$430k | US$412k | -US$20m |
| Sep 30 2023 | n/a | n/a | -US$22m |
| Jun 30 2023 | n/a | n/a | -US$22m |
| Mar 31 2023 | n/a | n/a | -US$20m |
| Dec 31 2022 | US$425k | US$401k | -US$20m |
| Sep 30 2022 | n/a | n/a | -US$19m |
| Jun 30 2022 | n/a | n/a | -US$20m |
| Mar 31 2022 | n/a | n/a | -US$20m |
| Dec 31 2021 | US$402k | US$375k | -US$22m |
| Sep 30 2021 | n/a | n/a | -US$24m |
| Jun 30 2021 | n/a | n/a | -US$28m |
| Mar 31 2021 | n/a | n/a | -US$28m |
| Dec 31 2020 | US$444k | US$357k | -US$29m |
| Sep 30 2020 | n/a | n/a | -US$29m |
| Jun 30 2020 | n/a | n/a | -US$28m |
| Mar 31 2020 | n/a | n/a | -US$30m |
| Dec 31 2019 | US$399k | US$347k | -US$32m |
| Sep 30 2019 | n/a | n/a | -US$34m |
| Jun 30 2019 | n/a | n/a | -US$33m |
| Mar 31 2019 | n/a | n/a | -US$31m |
| Dec 31 2018 | US$337k | US$337k | -US$30m |
| Sep 30 2018 | n/a | n/a | -US$24m |
| Jun 30 2018 | n/a | n/a | -US$24m |
| Mar 31 2018 | n/a | n/a | -US$23m |
| Dec 31 2017 | US$408k | US$328k | -US$22m |
Compensation vs Market: Maurice's total compensation ($USD430.28K) is below average for companies of similar size in the US market ($USD668.06K).
Compensation vs Earnings: Maurice's compensation has increased whilst the company is unprofitable.
CEO
Maurice Zauderer (76 yo)
23yrs
Tenure
US$430,277
Compensation
Dr. Maurice Zauderer, Ph.D. Co-Founded Vaccinex, Inc. in April 2001 and also serves as its President and Chief Executive Officer since April 2001. Dr. Zauderer serves as Director of Vaccinex Inc. since Apr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 23yrs | US$430.28k | 0.23% $ 21.4k | |
| COO and Senior VP of Discovery & Translational Medicine | 2.9yrs | US$303.21k | 0.0029% $ 272.5 | |
| Senior VP of Research & Chief Scientific Officer | 15.3yrs | US$308.90k | 0.0025% $ 231.2 | |
| Chief Financial Officer | less than a year | no data | no data | |
| Senior Vice President of Development | 15.3yrs | no data | 0.0010% $ 94.9 |
15.3yrs
Average Tenure
51yo
Average Age
Experienced Management: VCNX's management team is seasoned and experienced (15.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 23yrs | US$430.28k | 0.23% $ 21.4k | |
| Independent Director | 19.3yrs | US$82.50k | 0% $ 0 | |
| Independent Director | 21.1yrs | US$90.00k | 0% $ 0 | |
| Scientific and Clinical Advisor | no data | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Scientific and Clinical Advisor | no data | no data | no data | |
| Scientific and Clinical Advisor | no data | no data | no data | |
| Chairman of the Board | 23yrs | no data | 0.13% $ 12.4k | |
| Scientific & Clinical Advisor | no data | no data | no data | |
| Scientific & Clinical Advisor | no data | no data | no data | |
| Independent Director | 9.2yrs | US$85.00k | 0% $ 0 | |
| Independent Lead Director | 9.2yrs | US$75.00k | 0.11% $ 9.9k |
20.2yrs
Average Tenure
75.5yo
Average Age
Experienced Board: VCNX's board of directors are seasoned and experienced ( 20.2 years average tenure).